Literature DB >> 8301054

Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study.

E Silva1, R Sallie, C Tibbs, I McFarlane, P Johnson, R Williams.   

Abstract

Despite several studies from continental Europe reporting a high prevalence of antibodies to the hepatitis C virus (HCV), there has been little evidence of such infection in patients from the United Kingdom. The use of the polymerase chain reaction combined with two separate second generation anti-HCV assays is reported here in 58 UK patients with well-documented autoimmune chronic active hepatitis. All patients were in corticosteroid induced remission. All sera were collected prospectively for the specific purpose of this study. HCV-RNA was not detected by use of the polymerase chain reaction in any of the patients and antibodies to HCV were only detected in one patient. No evidence was found for the involvement of the hepatitis C virus in UK patients with classical, corticosteroid sensitive autoimmune chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301054     DOI: 10.1016/s0168-8278(05)80573-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  4 in total

1.  Treatment of autoimmune hepatitis.

Authors:  P J Johnson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Validation of scoring system for diagnosis of autoimmune hepatitis.

Authors:  A Czaja; H A Carpenter
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

4.  Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis.

Authors:  A J Czaja; S Magrin; C Fabiano; G Fiorentino; O Diquattro; A Craxi; L Pagliaro
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.